AGBK vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AGBK presents a stark contradiction between fundamental valuation and market performance. While the Piotroski F-Score of 5/9 indicates stable financial health and the P/E (5.78) and PEG (0.18) ratios suggest significant undervaluation, the stock is in a severe technical downtrend with a -30.7% return across all major timeframes. The high Price-to-Book ratio (9.64) is an anomaly for a regional bank and suggests the market is skeptical of the book value or expects further equity erosion. Despite a 'Strong Buy' analyst consensus, the lack of growth and bearish price action warrant a neutral stance.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
AGBK vs JPM: Head-to-Head Comparison
This page compares AGI Inc (AGBK) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.